Christina M. Ackermann
Net Worth

Last updated:

What is Christina M. Ackermann net worth?

The estimated net worth of Ms. Christina M. Ackermann is at least $15,008,474 as of 27 Feb 2022. She owns shares worth $1,307,266 as insider, has earned $4,531,208 from insider trading and has received compensation worth at least $9,170,000 in Bausch Health Companies Inc..

What is the salary of Christina M. Ackermann?

Ms. Christina M. Ackermann salary is $1,310,000 per year as Executive Vice President, Gen. Counsel & Head of Commercial Operations in Bausch Health Companies Inc..

How old is Christina M. Ackermann?

Ms. Christina M. Ackermann is 60 years old, born in 1965.

What stocks does Christina M. Ackermann currently own?

As insider, Ms. Christina M. Ackermann owns shares in one company:

Company Title Shares Price per share Total value
Bausch Health Companies Inc. (BHC) Executive Vice President, Gen. Counsel & Head of Commercial Operations 166,758 $7.84 $1,307,266

What does Bausch Health Companies Inc. do?

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

BHC logo
BHC
Bausch Health Companies Inc.
$7.84

Christina M. Ackermann insider trading

Bausch Health Companies Inc.

Ms. Christina M. Ackermann has made 5 insider trades between 2018-2022, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 121,198 units of BHC stock on 2 Jun 2021. As of 27 Feb 2022 she still owns at least 166,758 units of BHC stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Shares, No Par Value 24,292 N/A N/A
Option
Restricted Share Units 24,292 $24.35 $591,510
Sale
Common Shares, No Par Value 121,198 $31.83 $3,857,732
Option
Non-Qualified Stock Options (right to purchase) 60,345 $14.38 $867,761
Option
Common Shares, No Par Value 121,198 $14.85 $1,799,790
Option
Common Shares, No Par Value 121,198 $14.85 $1,799,790
Option
Restricted Share Units 8,455 N/A N/A
Option
Common Shares, No Par Value 8,455 N/A N/A
Purchase
Common Shares, No Par Value 4,390 N/A N/A
Option
Common Shares, No Par Value 7,864 N/A N/A
Option
Restricted Share Units 7,864 N/A N/A
Option
Common Stock, No Par Value 7,864 N/A N/A
Sale
Common Stock, No Par Value 3,418 $22.45 $76,727
Sale
Common Stock, No Par Value 3,968 $24.81 $98,446
Sale
Common Stock, No Par Value 4,542 $25.5 $115,821
Sale
Common Stock, No Par Value 15,404 $24.83 $382,481

Bausch Health Companies key executives

Bausch Health Companies Inc. executives and other stock owners filed with the SEC: